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Received 30 March 2016; revised 17 May 2016; accepted 17 May 2016AbstractProfound sensorineural hearing loss (PSHL) is not uncommonly encountered in otology. In clinics, there is a high incidence of otolithic
damage in patients with PSHL, but relevant reports are few. Sharing a continuous membranous structure and similar receptor cell ultrastructures,
the cochlea and vestibule may be susceptible to the same harmful factors. Disorders of the inner ear may result in a variety of manifestations,
including vertigo, spatial disorientation, blurred vision, impaired articulation, and hearing impairment. Considering the diversity of clinical
symptoms associated with PSHL with otolithic dysfunction, it may be frequently misdiagnosed, and objective means of testing the function of
otolithic organs should be recommended for hearing-impaired patients. Vestibular-evoked myogenic potentials (VEMPs) via air-conducted
sound are of great importance for the diagnosis of otolithic function. Hearing devices such as cochlear implants are commonly accepted
treatments for PSHL, and early identification and treatment of vestibular disorders may increase the success rate of cochlear implantation.
Therefore, it is necessary to increase awareness of otolithic functional states in patients with PSHL.
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Profound sensorineural hearing loss (PSHL) is a specific
form of sensorineural hearing loss (SNHL) caused by
congenital or acquired lesions of the cochlea, auditory nerve
and auditory center. The average air conduction audibility
frequencies are 500, 1000, 2000and 4000 Hz, in which
0e25 dB represents normal hearing, 26e40 dB mild damage,
41e60 dB moderate loss; 61e80 dB severe damage, and more
than 80 dB indicates profound hearing loss (Syka, 2002).
PSHL is not uncommonly encountered in otology (Xu et al.,
2016). The main features of PSHL are that it is most often
associated with congenital hearing loss and infectious dis-
eases. Congenital hearing loss is often bilateral and articula-
tion is commonly impaired, as hearing loss often develops
rapidly (Ozel et al., 2012). In addition to hearing loss,
symptoms associated with the vestibular system may appear
occasionally, such as nausea and vertigo. In children with
PSHL, the incidence of otolithic damage is very high (Xu
et al., 2015). It has been reported that the maximum possi-
bility of discovering vestibular malfunction in children with
hearing impairment is approximately 70% (Angeli, 2003), but
this issue has not received sufficient attention from physicians.
On account of the close physical connection between the
cochlear and vestibular systems e for example, the cochlea
and the saccule share the same membranous labyrinth (Sazgar
et al., 2006) e they are frequently affected by the same fac-
tors. That said, the pathophysiology and causes of many
conditions of the cochlear and vestibular systems remain to be
fully determined.
Routine vestibular function tests such as Romberg's test,
rotatory test and positional nystagmus test do not evaluate the
function of otolithic organs. For this reason, it remains
impossible to evaluate the degree of damage to the vestibular
system definitively via these routine vestibular tests. In some
situations, PSHL may potentially be accompanied by
dysfunction of otolithic organs, which can be detected via
vestibular-evoked myogenic potential (VEMP) responses (Xu
et al., 2016). VEMP test, an electrophysiological examination,
therefore deserves more attention. The main VEMP indexes
include amplitude, latency and threshold. It can detect disor-
ders of otolithic organs and the integrity of their pathways
accurately, and is an easy and simple test of vestibular func-
tions in clinical practice (Patko et al., 2003; Murofushi, 2016;
Kim et al., 2015). PSHL with vestibular problems may affect
individuals throughout their whole life, and may occur in
infants as well as elderly individuals. Physicians should
ensure that they are sufficiently knowledgeable in this area, in
order that they may provide optimal treatment to this group of
patients. Currently available hearing devices such as cochlear
implants and hearing aids have facilitated great progress in
hearing restoration. When physicians encounter PSHL,
attention should be paid to otolithic functions during both
diagnosis and treatment. VEMPs as a well-established test are
particularly suited to the detection of latent otolithic
dysfunction in patients.2. Etiology and clinical manifestations in patients with
PSHL2.1. EtiologyVarious causes of PSHL are encountered in otology clinics.
The major risk factors for congenital PSHL include consan-
guinity, maternal rubella, and exposure to intrauterine in-
fections, of which cytomegalovirus (CMV) infection is a
significant cause of bilateral PSHL in children (Toumpas et al.,
2014). Lack of an adequate vitamin A supply during preg-
nancy may result in the baby suffering developmental retar-
dation in hearing (Emmett and West, 2014). Compared to
congenital risks, the etiological factors of acquired PSHL are
many and varied. Of them, bacterial meningitis is common
among children (Karanja et al., 2013). A previously reported
analysis of 310 adult cases included meningitis (24.4%),
mumps (11.0%), unknown inflammatory diseases (16.6%),
idiopathic sudden sensorineural hearing loss (ISSNHL;
19.4%), chronic suppurative otitis media (CSOM; 6.0%),
trauma (6.1%), ototoxic medications (0.4%), and “no known
cause” (16.1%) as causes of acquired PSHL (Ozel et al.,
2012).
In addition to the above common factors, PSHL is often
accompanied by dysfunction of vestibular organs (Wang et al.,
2009). In one report, vestibular and cochlear symptoms
occurred simultaneously in more than half of the patients (Gao
et al., 2015). Given the similar physiological structures of the
cochlear and vestibular organs, it is hypothesized that PSHL
may prove to be significantly associated with vestibular dis-
orders, especially in children (Cushing et al., 2008).2.2. Clinical manifestationsIn a recent clinical report on 29 patients with PSHL, neither
the medical staff nor the patients themselves were mindful of
vestibular dysfunction (Xu et al., 2016). Vestibular function
can be normal or low in patients with PSHL. In one study, as
the extent of hearing impairment increased, the detection rate
reportedly gradually increased, although notably this result
was not statistically significant (Gao et al., 2015). The cochlea
and vestibule are closely related with regard to both anatomy
and histoembryology, and both may be prone to the same risk
factors. Notably, dysfunction of otolithic organs can cause a
variety of serious problems including imbalance, dizziness,
spatial disorientation and blurred vision. All these manifesta-
tions can be hidden and thus easily overlooked in patients with
PSHL (Zhou et al., 2009).
Some patients with PSHL do not exhibit typical features of
vestibular malfunction. For example, sometimes vertigo is not
apparent even if the saccule is damaged (Hong et al., 2008).
The most common chief complaint in PSHL patients may be
“no response to sounds” (Xu et al., 2015), while vestibular
dysfunction may also have a negative impact on the physical
development in children with PSHL, in the form of delayed
acquisition of head control or independent walking, or
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dizziness is present, it is often associated with a poor prog-
nosis (Wang et al., 2009). Moreover, hearing-impaired patients
are not capable of hearing voices perfectly, and consequently
can progressively lose the ability to communicate with others,
such that language function degrades slowly (Dehqan and
Scherer, 2011).
3. Function of otolithic organs in patients with PSHL3.1. AnatomyThe vestibular system has a complicated structure, formed
by divisions of the lateral, anterior and posterior semicircular
canals, and the otolithic organs (saccule and utricle). The
semicircular canals provide sensory input pertaining to angular
velocities, and the otolithic organs are sensitive to linear and
gravitational acceleration (Ciaravella et al., 2007). The saccule
and utricle play an important role in maintaining balance by
affecting the muscular tonus and influencing positional
sensation. The cochlea and vestibule are functionally and
anatomically associated as they share a continuous membra-
nous labyrinth and similar receptor cell ultrastructures, and are
supplied by a common arterial vessel known as the labyrin-
thine artery (Xu et al., 2016; Wang et al., 2016). Therefore, it
is reasonable to hypothesize that inner ear diseases may affect
both the vestibular system and the cochlea, or in other words,
that people with cochlear hearing damage may also have
vestibular deficiency (Singh et al., 2012). Therefore, patients
with PSHL should have their vestibular organ functions tested,
especially those of the otolithic organs.3.2. Otolithic organ testsFor a long time, a lack of means to test otolithic organs has
meant that most clinicians are relatively unfamiliar with the
development of otolithic (saccular and utricular) dysfunction
in patients (Young, 2015). As a result, there have been rela-
tively few relevant studies to date. The function of otolithic
organs can be evaluated by the VEMP test, which was first
reported by Colebatch et al (Colebatch and Halmagyi, 1992) in
1992, and has since been the subject of substantial research. It
is now the standard test for otolithic function in people with
vestibular impairment. Two types of VEMP tests are currently
available: the cervical VEMP (cVEMP) test and the ocular
VEMP (oVEMP) test (Curthoys et al., 2011). The cVEMP test
can reportedly reflect saccular function and the functioning of
the inferior vestibular nerve input pathway, which has strong
projections to the sternocleidomastoid muscle but only weak
projections to the oculomotor system (Walther and Blodow,
2013). The oVEMP test can reportedly reflect utricular func-
tion and the functioning of the superior vestibular nerve input
pathways, which have strong projections to the oblique muscle
of the lower eyelid (Niu et al., 2016). In the oVEMP test,
VEMPs generated by activation of utricular afferents and
mediated by a crossed otolith-ocular pathway are analyzed
(Niu et al., 2016). A recent theory proposed by Govender et al(Govender et al., 2015) suggests that saccular components
comprise 74% (utricular components ¼ 26%) of air-conducted
500 Hz cVEMPs, and 61% (utricular components ¼ 39%) of
bone-conducted 500 Hzc VEMPs resulting from stimulation at
the forehead (AFz). Moreover, according to the theory, utric-
ular components comprise 68% (saccular components ¼ 32%)
of air-conducted 500 Hz oVEMPs, and 80% (saccular
components ¼ 20%) of bone-conducted 500 Hz (AFz)
oVEMPs. That said, cVEMP and oVEMP tests in humans
yield values that match those ascribed to saccular and utricular
components by theory.
The two types of VEMPs play important roles not only in
assessing common vestibular diseases such as vestibular
migraine, Meniere's disease and vestibular neuritis, but also in
detecting new clinical entities (Murofushi, 2016). Addition-
ally, oVEMP and cVEMP tests are easy to perform non-
invasively, and the results they yield are highly reliable.
Notably, a recent study has shown that cVEMPs can be eli-
cited in newborns at day 5, but that oVEMPs cannot be elicited
in the neonatal period (Young, 2015). The cVEMP and
oVEMP tests are in dispensable as clinical tools, and aware-
ness regarding them should be increased.3.3. Dysfunction of otolithic organs in patients with
PSHLThe relationship between hearing level and vestibular
dysfunction in PSHL patients remains unclear. Recently, based
on evaluations of otolithic organ function via cVEMP and
oVEMP tests, some researchers have proposed that otolithic
organs and their input pathways may be damaged in patients
with PSHL (Xu et al., 2015, 2016). The impairment or absence
of VEMPs indicates dysfunction of otolithic organs. In a
recent investigation, Xu et al (Xu et al., 2016) detected
oVEMP responses in 38.9% of ears in patients with PSHL,
while the response rate was 100% in healthy subjects. In that
same study, 44.4% of ears in patients with PSHL yielded
cVEMPs, while the response rate in healthy subjects was
100%.These data demonstrate that patients with PSHL have a
high incidence of damage to the otolithic organs. Similarly, Xu
et al (Xu et al., 2015) investigated oVEMP and cVEMP results
in 43 children with PSHL and 20 healthy children, and found
that oVEMPs were induced in 58.1% of ears in children with
PSHL, while the response rate in the healthy children was
100%.Similarly, cVEMPs were induced in 61.9% of ears in
children with PSHL, while the response rate in the healthy
children was 100%.While many children with PSHL may not
exhibit symptoms of otolithic organ dysfunction, it is none-
theless important to pay attention to vestibular function. A
study reported by Jafari et al (Jafari and Asad, 2011) also
showed that vestibular disorder may accompany hearing
damage in patients with PSHL. Thus, in both children and
adults with PSHL, attention should be paid to otolithic organ
function, and cVEMP and oVEMP tests should be performed.
Zuniga et al (Zuniga et al., 2012) reported a strong asso-
ciation between hearing loss and saccular function, suggesting
that PSHL patients may exhibits saccular and inferior
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patients with diagnosed sensorineural hearing loss may
already have saccular disorders. There is a correlation between
saccular dysfunction and the extent of hearing loss in children
with PSHL, suggesting that saccular dysfunction may be a
concomitant indicator of the severity of hearing disorders
(Emami and Farahani, 2015). Sazgar et al (Sazgar et al., 2006)
showed that patients with SNHL were likely to have sub-
clinical disorders of the vestibular system, particularly disor-
ders involving the saccule. Similarly, Zhou et al (Zhou et al.,
2009) detected abnormal cVEMPs in 91% of children with
PSHL, and also showed that the cVEMP threshold was higher
in these children. Thus, evidently, abnormality of saccular
function is associated with PSHL. Another study reported that
only 26.9% of patients with PSHL exhibited abnormal or
absent cVEMP responses, but it also showed that the more
severe the hearing loss, the more likely the saccule was to be
involved (Hong et al., 2008).
4. Treatment
Cochlear implantation (CI) is one of the most widely
utilized and reliable treatment options for patients with
PSHL. The aims of CI are to restore hearing and improve the
quality of life of patients with severe deafness. Vestibular
dysfunction has a negative impact on the physical develop-
ment of children with PSHL (Yawn et al., 2015). CI can
augment hearing, thereby improving the understanding of
speech and environmental sounds. After implantation, chil-
dren with PSHL can acquire spoken language, communicate
with others and attend school. However, not every patient
with PSHL can undergo successful CI, which requires inte-
grated vestibulocochlear nerves. Specifically, if the site of the
patient's lesion is not outside the central auditory processing
stream, CI may not work (Roche and Hansen, 2015). While
cochlear implants may improve hearing in patients with
PSHL, many patients still use hearing aids instead. Hearing
aids are small eletroacoustic devices that can amplify and
modulate sound (Ching et al., 2015). Apart from cochlear
implants and hearing aids, gene therapy is a new biological
treatment modality for PSHL, aimed at preventing hair cell
death, and regulating hair cell differentiation (Wang et al.,
2015). Many patients with PSHL have genetic mutations,
and to date, in many of these cases, there are no biological
treatments available (Askew et al., 2015). We believe that in
the future, gene therapy will become a useful strategy for
treating patients with PSHL.
These kinds of therapies, particularly CI, can improve
hearing in patients with PSHL (Yu et al., 2015), but they are
not effective treatments for dysfunction of otolithic organs.
There are several therapies for otolithic disorders, such as
vestibular rehabilitation training and a number of medications.
Vestibular rehabilitation training is generally the first recom-
mended treatment. Under the guidance of a physician, patients
undergo various kinds of rehabilitation exercises in order to
improve balance and maintain stable vision, as well as the
interaction between the visual and somato-sensory systemsand the vestibular organs at the brainstem level (Murray et al.,
2010). This physiotherapy has a profound therapeutic effect on
PSHL patients with vestibular dysfunction and is suitable for
the elderly. Conventional pharmacological treatments may
help alleviate symptoms, but have less curative effects than
vestibular rehabilitation training. Some of these drugs such as
anticholinergics may have undesired side effects. In brief,
dysfunction of otolithic organs should be diagnosed correctly
in patients with PSHL, and it is necessary to provide appro-
priate treatment.
5. Prognosis
Not all cochlear implants survive for long periods, and
surgical replacement is a common source of complications
(Eskander et al., 2011). The effect of treatment for PSHL can
be influenced by many factors, including the function of
otolithic organs. A study by Wolter et al (Wolter et al., 2015)
suggested that children who experienced CI failure had more
balance problems than those in whom CI was successful. It
also revealed that early identification and treatment of disor-
ders of otolithic organs might increase the success rate of CI
and prevent impeded language acquisition. In another study,
Parietti-Winkler et al (Parietti-Winkler et al., 2015) showed
that vestibular evaluations were important in the follow-up of
CI, and that vestibular function should be taken into account in
the decision-making process prior to CI.
On one hand, lesions of otolithic organs can increase the
risk of CI failure, and on the other hand, CI can damage
otolithic organs. According to the literature, impairments of
the vestibule can be found in many patients after CI (Robard
et al., 2015). Thus, alterations of the inner ear associated with
CI can cause vestibular disorders. Reduced vestibular system
function is also reported frequently after CI. Fina et al (Fina
et al., 2003) reported that 39% of patients who underwent CI
experienced symptoms of vertigo after the surgery. Given that
an increasing number of patients with PSHL may undergo CI
in the future, the function of otolithic organs should be tested
not only before CI, but also after the surgery.
6. Conclusion
From the present review, it is hard to determine the cau-
sality between PSHL and vestibular dysfunction, and relevant
research on the relationship between them is lacking. Clinical
manifestations in patients with PSHL are variable, and
impairment of vestibular function can be concealed by hearing
loss and thus overlooked. Given these considerations, VEMP
testing should be used as an objective procedure to evaluate
potentially hidden dysfunction of the otolithic organs during
diagnosis and treatment.
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